Post Categories
Meet QPS at the EAACI in Lisbon
May 9, 2019
Professor Zuzana Diamant, EAACI Asthma Section Chair (2017-2019), will chair and lecture at the EAACI (European Academy of Allergy and Clinical Immunology) symposium in…
Meet QPS at the ATS in Dallas
May 9, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
DDI Studies: The Final Frontier?
May 9, 2019
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
Challenging the Inhaled Allergen Challenge
May 9, 2019
Presently, the QPS Respiratory Team is making progress on a large data-intensive, 2-centre allergen challenge study in eosinophilic allergic asthma testing an innovative new…
QPS has a Strong Competency in Alzheimer Research
May 9, 2019
The results of a research collaboration between the neuroscience group of QPS Netherlands B.V. and Professor Peter Paul de Deyn and coworkers of the…
QPS will exhibit at the World Vaccine Congress
April 15, 2019
QPS will exhibit at the World Vaccine Congress, April 15-17 in Washington, DC. Please stop by our booth #600 to learn more about QPS’…
BREXIT IMPACT: More Questions Than Answers
March 30, 2019
Later this month the United Kingdom (UK) is expected to achieve independence from the European Union (EU) based on a referendum that was passed…
QPS is exhibiting at the 13th Annual WRIB Meeting
March 27, 2019
QPS is exhibiting at the 13th Annual WRIB Meeting, April 1-4 in New Orleans, LA. If you are attending, please visit us at booth…
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany.
October 4, 2018
QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Please stop by our Booth #5 to learn…
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
Are the New COVID Boosters Better Than the Old Boosters?
November 2, 2022
This fall, the FDA approved the rollout of two updated Omicron-specific COVID-19 boosters. These new COVID boosters aim to provide more protection against the…
Research Reveals a Fungi-Cancer Connection, with Potential Diagnostic Implications
October 31, 2022
Like bacteria, fungal microorganisms are an important part of the human microbiome and essential to human health. Scientists studying the microbiome over the past…
Can Nasal Vaccines Confer Sterilizing Immunity?
October 26, 2022
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
